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Introduction
Fever can often  remain unexplained despite testing for 
specific human pathogens. Fever of unknown origin may 
reflect infections with known but untested pathogens, still 
uncharacterized and possibly emerging infectious agents, or 
be due to non-infectious causes. Testing of blood samples 
from such unexplained febrile cases has revealed the pres-
ence of human viruses including anelloviruses and pegivirus 
A (GBV-C), hepatitis A, HHV-6, Dengue 2, and parvovirus 
B19 in febrile patients from Nicaragua [1] and the same 
viruses plus HIV, HBV, rhinovirus C, Merkel cell poly-
omavirus, and the enteric norovirus and rotavirus in febrile 
Kenyans [2]. Plasma from febrile Nigerians yielded Dengue 
2 virus, Lassa virus, pegivirus A, herpesvirus 4/5/8, HIV, 
HBV, HCV, and two novel rhabdoviruses detected in febrile 
as well as healthy individuals [3]. This study indicated that 
sequencing blood from febrile patients can result in the 
identification of previously unknown and possibly emerg-
ing viruses.
Here, we analyzed human sera from individuals from 
Peru with unexplained fever and identified both known com-
mensal and pathogenic human viruses as well as viruses 
whose tropism are not known to include vertebrates.
Materials and methods
Clinical samples
Serum samples were collected from patients with unex-
plained fever in Peru. These samples had pre-tested nega-
tive for dengue virus [4], zika virus [5], chikungunya virus 
[6], oropouche virus [7], mayaro virus [8], bartonella [9], 
and leptospira [10] bacteria. The self-defined inclusion 
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criteria were patients who presented in the outpatient clin-
ics with acute, undifferentiated, febrile illness (greater than 
or equal to 38 °C axillar temperature for 7 days of duration 
or less) along with one or more of the following symptoms: 
headache, muscle pain, ocular and/or joint pain, nausea, 
vomiting, sore throat, cough, rhinorrhea, difficulty breath-
ing, diarrhea, jaundice, generalized fatigue, and cough. 
Exclusion criteria were if an identifiable focus of infection 
was diagnosed, such as sinusitis, pneumonia, acute otitis 
media, or other acute infections. This study was approved 
by the Research Ethics Board of the Hospital Regional de 
Cajamarca, Peru. A written informed consent was signed 
before enrollment; for participants under 18-year old, the 
informed consent was signed by parents or children caregiv-
ers before enrollment.
Viral metagenomics
A total of 88 serum samples from different patients were first 
analyzed in pools of 4–5 samples using a viral metagenomic 
approach. Each pool was clarified by 15,000×g centrifuga-
tion for 10 min, and then filtered through a 0.45-µm filter 
(Millipore). The filtrate was treated with a mixture of nucle-
ase enzymes to digest unprotected nucleic acids and also 
to deplete ribosomal RNA [11]. Viral nucleic acids were 
extracted using a Maxwell 16 automated extractor (Pro-
mega). cDNA and DNA were then generated by using ran-
dom RT-PCR followed by the use of the Nextera XT Sample 
Preparation Kit (Illumina) to construct a DNA library [11]. 
An Illumina MiSeq run of 250 bases paired-end reads was 
generated whose data were deposited in GenBank’s short 
read archive (SRP102377). After quality control removal 
of duplicate reads and reads shorter than 50 bases, the Vec-
Screen program was used to remove Illumina primers poten-
tially missed by Illumina’s default primer removal. Viral 
sequences were then identified through translated protein 
sequence similarity search (BLASTx) to all annotated viral 
proteins available in GenBank’s viral RefSeq database.
Genome acquisition of new RNA viruses
Complete genomes of dicistrovirus (GenBank KY973643) 
and partitivirus (GenBank KY973644 and KY973645) were 
recovered by de novo assembly using the Ensemble program 
integrating the sequential use of de Bruijn graph (DBG) and 
overlap-layout-consensus assemblers (OLC) with a parti-
tioned sub-assembly approach [12]. Putative ORFs in the 
new genomes were identified using the NCBI ORF finder. 
All alignments and phylogenetic analyses were based on in 
silico translated amino acid sequences. Sequence alignment 
was performed using CLUSTAL X [13]. Sequence identity 
was determined using BioEdit. Phylogenetic trees with boot-
strap resampling of the alignment datasets were generated 
using the maximum likelihood method with the WAG model 
that was tested and recommended by the program MEGA 
version 6 [14]. Bootstrap values (based on 100 replicates) 
for each node are shown if > 70%.
PCR assays for dicistrovirus and partitivirus
In order to identify the individual sample within the pools 
that contained dicistrovirus or partitivirus viral RNA ini-
tially detected by deep sequencing, two sets of PCR primers 
were used for nested RT-PCR assays with primers designed 
based on the short read sequence data. For the RT step, viral 
nucleic acids were added to a reagent mixture consisting of 
first-strand buffer (Invitrogen), dNTP (Thermo Scientific), 
superscript reverse transcriptase III (Invitrogen), random 
primer, and RNase inhibitor (Thermo Scientific). The RT 
step was carried out at 25 °C for 5 min, 50 °C for 1 h, 70 °C 
for 15 min, and then the mixture was held at 4 °C.
For dicistrovirus, primers PEDiV-F1 (5′-681CAC CCC 
GTT GCA TTT GTT CGC  TCT704-3′) and PEDiV-R1 
(5′-715TCA CAG TCT CCT TCA ACA CAG AAA TCC 
 AT744-3′) were used for the first round of PCR, and primers 
PEDiV-F2 (5′-1173AAG TGA ACA TAG TTG ATG AAA 
GAA CCC  CGA1197-3′) and PEDiV-R2 (5′-1212GCA TAG 
CAA CGT CCA TCC TCC TAC  A1240-3′) for the second 
round of PCR. The PCR conditions in these two assays were 
95 °C for 5 min, 35 cycles 95 °C for 30 s, 55 °C (for the first 
or second round) for 30 s, and 72 °C for 1 min, a final exten-
sion at 72 °C for 10 min, resulting in an expected amplicon 
of 483 bp for dicistrovirus.
For partitivirus, segment-2 primers PEPartiV-F1 (5′-
167CAA CTG GAA ATA CAG CAT CGT CTG  A191-3′) and 
PEPartiV-R1 (5′-205GAG TCG GGA GCG GGT ATC AAG 
 T225-3′) were used for the first round of PCR, and prim-
ers PEPartiV-F2 (5′-596ACC CTT GAC CTT CCC AAC 
 CGA617-3′) and PEPartiV-R2 (5′-621TGA GGA AGC ATG 
GAT TGA AGG  A642-3′) for the second round of PCR. The 
PCR conditions in these two assays were 95 °C for 5 min, 35 
cycles 95 °C for 30 s, 52 °C (for the first or second round) 
for 30 s, and 72 °C for 1 min, a final extension at 72 °C for 
10 min, resulting in an expected amplicon of 413 bp for 
partitivirus.
PCR assay for fungi ITS
PCRs with two sets of universal primers for fungal ITS-1 
and ITS-2 amplification were performed [15, 16]. Primers 
ITS1 (5′-TCC GTA GGT GAA CCT GCG G-3′) and ITS2 
(5′-GCT GCG TTC TTC ATC GAT GC-3′) should yield 
a 145-695 bp amplicon. Primers 5.8S-Fun (5′-AAC TTT 
YRR CAA YGG ATC WCT-3′) and ITS4-Fun (5′-AGC 
CTC CGC TTA TTG ATA TGC TTA ART-3′) should yield 
a 267–511 bp amplicon. The PCR condition in these two 
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assays were 96 °C for 2 min, 40 cycles 94 °C for 30 s, 55 °C 
for 40 s, and 72 °C for 2 min, a final extension at 72 °C for 
10 min.
PCR assay for insects COI
PCRs with two sets of universal primers with some modifi-
cations for insect COI-5P amplification were performed [17, 
18]. Primers C_LepFolF (5′-RKT CAA CMA ATC ATA 
AAG ATA TTG G-3′) and MLepR2 (5′-GTT CAW CCW 
GTW CCW GCY CCA TTT TC-3′) should yield a 307 bp 
amplicon. Primers MLepF1 (5′-GCT TTC CCA CGA ATA 
AAT AAT A-3′) and C_LepFolR (5′-TAA ACT TCW GGR 
TGW CCA AAA AAT CA-3′) should yield a 407 bp ampli-
con. The PCR condition was followed as previously pub-
lished [18].
Results
Eighty-eight serum samples from Peruvian patients with 
unexplained fever were analyzed in 18 pools of 4–5 sam-
ples using one Illumina MiSeq run of 250 base paired-ends 
sequencing. Using a stringent BLASTx cutoff of E scores 
< 10−20, the most numerous viral sequence reads were 
from diverse anelloviruses (18 positive pools), followed 
by pegivirus A (aka GBV-C) (5 pools), dengue virus 2 
(DENV2: 4 pools), Oropouche virus (OROV: 2 pools), and 
HIV (1 pool) (Table 1).
In order to search for novel viral sequences (without 
very close relatives in GenBank), we also lowered the 
stringency of the protein matches to BLASTx E score 
of  10−5. We detected a large number of dicistrovirus and 
partitivirus protein coding reads in two different serum 
pools. One pool which generated 1.1 × 105 sequence reads 
included 2232 reads related to dicistroviruses, and another 
pool which generated 5.2 × 104 sequence reads included 
372 reads related to partitiviruses. The nucleic acids of 
the four sera in the partitivirus-positive pool and the five 
sera in the dicistrovirus-positive pool were individually 
extracted using a different extraction method (QIAamp 
Viral RNA Mini Kit) and tested for the dicistrovirus and 
partitivirus RNA by RT-PCR (Materials and methods sec-
tion), to identify the virus positive serum samples within 
each pool. These two sera were then individually analyzed 
by viral metagenomics and the data were deposited in 
GenBank’s short read archive (SRP103886). Sequencing 
again revealed partitivirus and anelloviruses in one serum 
sample and dicistrovirus in the other sample as the only 
viral sequences using an E score cutoff of < 10−5.
Table 1  Distribution of sequence reads to different viruses in 18 sera pools from Peru
*Pools highlighted contain the initial new dicistrovirus and partitivirus sequence reads further analyzed in individually infected samples SF537 
and C-11  
Pool ID No. of reads Annellovirus Pegivirus Dengue virus Oropouche virus HIV Dicistrovirus Partitivirus
21 125715 26 6
22 241021 53
23 50623 195
24 85094 563 26
25 589125 18
26 100744 43 165




31 34905 21 374
32* 110015 396 28802 2232
33 95898 66 24 17




38 60026 3839 1780 10062
Individual SF573 47589 78
Individual C-11 42727 2761 11574
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The nearly complete genomes of the dicistrovirus and 
partitivirus were generated using de novo assembly (Materi-
als and methods section).
The dicistrovirus was named human blood-associated 
dicistrovirus—HuBDV, and was 9566 bases in length, 
including two major ORF-1 and -2 (Fig.  1a). The first 
ORF (5′ ORF) coded for the non-structural polyprotein 
(1959 aa), and showed the highest protein identity (18 or 
26% similarity) to that of wenzhou picorna-like virus 26 
reported in snails (GenBank KX884379) [19]. The second 
ORF (3′ ORF) coded for the structural polyprotein (944 aa), 
and shared the best identity of 19% (25% similarity) to that 
of aphid lethal paralysis virus (GenBank AF536531) [20] 
belonging to the genus Cripavirus. The conserved motifs 
of RNA helicase [GKTGVGK] [21] and protease [GDCG] 
[22] were found in the non-structural polyprotein [conserved 
amino acid in boldface and underlined]. Additionally, three 
repeated VPg-like sequences [SxQxRTxGxxRRNVE] were 
found [23]. The C-terminal region of the HuBDV’s non-
structural polyprotein contained a RNA-dependent RNA 
polymerase (RdRP). A putative non-ATG start codon was 
identified for the HuBDV’s structural polyprotein, a phe-
nomenon also observed in other dicistroviruses such as 
cricket paralysis virus (Genbank KP974706), drosophila C 
virus (GenBank AF014388), and aphid lethal paralysis virus 
(Genbank AF536531). The pair-wise amino acid sequence 
analysis demonstrated that the structural polyprotein con-
tained capsid proteins VP1-VP4 (Fig. 1a). A phylogenetic 
analysis of both polyproteins is shown (Fig. 1b). Based on 
ICTV, the members of a dicistrovirus species should share 
above 90% aa identity in their capsid region [24]. Since very 
low identities (≤ 19%) were measured between HuBDV’s 
capsid and its closest relatives, HuBDV can be considered a 
member of a new species or even a new genus in the family 
Dicistroviridae [24].
The genome of the novel partitivirus, referred to as human 
blood-associated partitivirus—HuBPV, consisted of two 
segments (Fig. 2a). The first segment was 2168 bp in length 
with GC content of 44%, and contained a single ORF encod-
ing a RNA-dependent RNA polymerase (RdRp). The second 
segment was 2161 bp in length with GC content of 47%, 
and contained a single ORF encoding a capsid protein. The 
RdRp (675 aa in length) and capsid (653 aa in length) pro-
teins showed the closest identities of 63% (65% similarity) 
and 55% (55% similarity) to those of a fungus (atkinsonella 
hypoxylon) partitivirus (GenBank L39125 and L39126), 
with the next closest identities of 59% (61% similarity) 
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Fig. 1  New dicistrovirus. a Genome organization. b Phylogenetic 
trees generated with non-structural and structural polyproteins of 
dicistrovirus detected in a Peruvian patient with unexplained fever 
and genetically related dicistroviruses in the family Dicistroviridae. 
The scale indicates amino acid substitutions per position
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partitivirus (GenBank AY260756 and AY247205). Analysis 
of the deduced amino acid RdRp sequences revealed six 
conserved motifs among mycoviruses, SHPDKLKVRPVY-
NAPMIYLR, IDWSRFDHLAP, GVPSGILMTQFFDS-
FVNLTIL, LIMGDDNVALT, GMKINIDKSSSTSIRRKI-
EVLGY, and RSISKLVGQLAYPER [conserved amino acid 
in boldface and underlined] [25]. Phylogenetic analysis of 
the RdRp and capsid proteins showed that HuBPV grouped 
together with other partitiviruses in the genus Betaparti-
tivirus (Fig. 2b). According to the ICTV, partitiviruses in 
the same genus should share at least 40% aa identity in the 
RdRp region (Delmas, 2012). Genome analysis therefore 
indicated that HuBPV should be considered a new member 
of the genus Betapartitivirus.
In order to further investigate the origins in human serum 
samples of the partitivirus and dicistrovirus (known to infect 
fungi and arthropod, respectively), we used PCR assays to 
test for DNA from their putative cellular hosts in the human 
sera. Two sets of PCR primers targeting the highly con-
served internal transcribed spacer region between the small 
and large rRNA genes (ITS1/2) of fungi were used to test for 
the presence of fungal DNA [15, 16]. Arthropod DNA was 
tested for using a PCR targeting the conserved cytochrome 
c oxidase subunit I gene (COI-5P) [18] of arthropods (Mate-
rials and methods section). The DNA of twenty individual 
Peruvian serum samples including the two positive for the 
dicistrovirus and the partitivirus were extracted (QIAamp 
Viral RNA Mini Kit) and tested by PCR. No sample was 
positive for the arthropod DNA CROI region. Only one 
serum was positive for the fungi ITS1/2 DNA, the same 
sample positive (C-11) for the partitivirus RNA (Fig. 3). 
Both fungal ITS1/2 PCRs were positive. Analysis of the 
longer 566-base-long ITS fragment (Genbank KY973646) 
by Sanger sequencing indicated that its closest relative 
(563/566 bases identity) was from bipolaris sorokiniana 
(GenBank JQ936306.1) a fungus reported to infect cere-
als. The presence of three mismatches between these ITS1/2 
sequences prevent a definitive assignment of the origin of 
the fungal DNA in the human sera.
Discussion
In the study, we describe the viruses identified in sera 
from people with fever from Peru, the nearly complete 
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Fig. 2  New partitivirus. a Genome organization. b Phylogenetic 
trees generated with non-structural and structural proteins of partitivi-
rus detected in a Peruvian patient with unexplained fever and geneti-
cally related partitiviruses in the family Partitiviridae. The scale indi-
cates amino acid substitutions per position
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and the detection of fungal DNA in the partitivirus contain-
ing serum. The known human viruses detected are either 
considered commensal (anelloviruses and pegivirus A) or 
are known pathogens (Dengue 2, Orouche, HIV). GBV-
C, recently renamed pegivirus A, is a common flavivirus 
infection associated with blood contact but has not been 
associated with fever or other diseases [26]. Infections with 
anelloviruses are also considered non-pathogenic [27]. The 
pathogenicity of Dengue 2 virus, a flavivirus arbovirus, and 
its detection in South America has been extensively docu-
mented [28]. The samples analyzed were pre-screened using 
a real-time RT-PCR assay to exclude Dengue virus RNA-
positive samples. Our metagenomics detection of Dengue 
viral sequences indicates that some positive samples were 
missed by that assay either due to low viral loads or in the 
case of pool 27 with > 60,000 viral reads possibly due to 
sample or data mix up. Oropouche, an orthobunyavirus arbo-
virus, has been reported in the Western hemisphere initially 
in the Caribbean in 1955 [29] and most recently in Peru in 
2016 [30]. Here two pools of serum collected in Peru in Jan-
uary–February 2016 contained Oropouche sequences. Oro-
pouche virus is a frequent cause of arboviral disease in Latin 
America believed to be transmitted in its urban/epidemic 
cycle by the mosquito Culex quinquefasciatus and/or the 
biting midge Culicoides paraensis [31]. Detection of Oro-
pouche together with Dengue 2 virus further highlight that 
sampling of febrile patients can detect the short term viremia 
typical of such arboviral infections [1–3].
The detection of viral nucleic acids from viral families not 
known to infect vertebrates was further evaluated to exclude 
possible contamination during nucleic acid extraction or 
library preparation. The presence of contaminating viral 
nucleic acids have been reported from samples extracted [2, 
32–34] using Qiagen silica-based extraction columns. Sera 
were therefore re-extracted using an alternative method and 
the presence of dicistrovirus and partitivirus viral RNA in 
the two sera samples was confirmed by RT-PCR.
Dicistroviruses belong to the family Dicistroviri-
dae with small linear ssRNA genome of approximately 
8–10 kb and an internal ribosome entry site separating two 
main ORFs encoding non-structural and structural pro-
teins whose functional domains distantly resemble those 
of picornaviruses. Dicistrovirus is known to infect inver-
tebrates and is responsible for several arthropod diseases, 
often causing paralysis in their hosts [35]. Dicistroviruses 
have also been reported in the feces of insectivorous bats 
[36] and goose [37]. The dicistrovirus genome amplified 
from serum is deeply rooted within the Dicistroviridae phy-
logeny and highly divergent from its closest known relatives, 
the Taura syndrome virus [38] infecting Pacific white shrimp 
Litopenaeus vannamei [39] in the genus Aparavirus and an 
unclassified dicistrovirus from a mud crab (GenBank RefSeq 
accession number NC_014793). As no arthropod DNA was 
identified using PCR targeting a highly conserved arthro-
pod locus, the presence of the dicostrovirus RNA genome in 
the serum of a febrile patient remains unexplained. Patient 
infection with an arthropod refractory to the PCR primers 
used or a non-arthropod invertebrate infected with the dicis-
trovirus remain a possibility as does an insect bite transfer-
ring dicistrovirus particles but little insect DNA. Replication 
in human cells seems unlikely given the currently known 
tropism of other dicistroviruses.
The family Partitiviridae is a group of viruses with bi-
segmented genomes comprising two dsRNA segments, of 
1.4–2.3 kb currently classified into 5 genera, 4 of which 
infect plant or fungi (Alphapartitivirus, Betapartitivirus, 
Gammapartitivirus, Deltapartitivirus), while the fifth genus 
(Cryspovirus) infects a protozoa (Cryptosporidium spp.). 
Partitiviruses are often associated with latent infections with 
no apparent symptoms on their fungal hosts [40] but which 
may lead to either hyper or hypovirulence of the infected 
fungi upon their hosts [41–44]. A new partitivirus was 
recently found infecting an emerging North American, but 
not European, fungal pathogen causing fatal white-nose syn-
drome of hibernating bats in North America [45].
The serum-associated partitivirus was found in the pres-
ence of fungal ITS ribosomal DNA most closely related 
to that of cereals-infecting Bipolaris sorokiniana (Com-
mon Root Rot and Spot Blotch of Barley and Wheat) in 
the fungal family Pleosporaceae but sequence mismatches 
prevented a definitive assignment to a specific fungal spe-
cies. The genus Bipolaris includes several significant plant 
pathogens of the family Poaceae (grasses), including rice, 
maize, wheat, and sorghum [46], and is closely related to 
Fig. 3  Fungal DNA amplifi-
cation. PCR assay using uni-
versal fungal primers tar-
geting ITS1 and ITS2 was 
performed. The HuBDV par-
titivirus RNA positive serum 
sample was found positive for 
fungal ITS DNA while eighteen 
other serum samples were 
negative
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the genus Curvularia which includes several human and 
plant fungal pathogens [47].
Possible explanations for the detection of partitivirus 
RNA in human serum include transfer of viral particles from 
fungi in the digestive track to the blood, contamination from 
fungi present on the skin during phlebotomy or airborne 
fungal spores during serum sample aliquoting. We recently 
described the presence of another putative fungal virus in 
large plasma pools used for biological products production 
[48]. A more intriguing possibility from our current find-
ing is that the fungal virus found in a human serum reflects 
infection of this febrile patient with a partitivirus-infected 
fungus. While fungal infections are rare relative to bacterial 
infections, they can also result in fever and be particularly 
difficult to diagnose and treat [49].
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